PPT-Zeroing In on the Differential Diagnosis and Hemodynamics of Pulmonary Hypertension

Basic Definitions Differentiating PAH From PVH PVH Essential Tests to Evaluate PH Differentiating PAH From PVH Differentiating PAH From PVH cont Essentials of Performing RHC Essentials of Performing RHC cont. of Pulmonary Hypertension. Dr. Christopher J Arendt, . PharmD. , . RPh. Assistant Professor of Pharmacy. Mayo Clinic College of Medicine. Rochester, Minnesota. Disclosure. Nothing to disclose. No financial interests. Professor of Medicine. Chief of Cardiology. Associate Chief Cardiology. University California Irvine. Orange, California. Hemodynamic Problems for the Cath Lab. Valvular heart disease:. Aortic stenosis/insufficiency. Circulation 2014;129:587-597. Teaching Tool: Hyperfiltration Early Sign of Hypertension and Diabetes. J Am Soc Nephrol 2017;28:1023-1039. Hyperfiltration Early in . Diabetic Nephropathy. Circulation 2016;134:752-772. Rajan Joshi MD,FCCP, FAASM. Assistant Professor, Pulmonary Critical care, Sleep Medicine at UKHC. Medical Director, Pulmonary Rehabilitation, UKHC, Lexington. KY. TLC & Sleep Center-PR, Richmond, KY. . Focus: Alter diameter, length and position of fistula and monitor changes in hemodynamics of system. CFD (Computational Fluid Dynamics) Modeling. . Focus: Alteration of fistula diameter and the resulting changes in flow patterns. ulmonary Hypertension. Dr Dolores Taboada MD. Consultant Cardiologist. Pulmonary Vascular Disease Unit. Papworth Hospital, Cambridge, UK. My disclosures. I have received honoraria . from . Actelion. , Bayer, . By: Ahmad Al-Masri. Definition . defined . as . mean. pulmonary artery . pressure of . ≥ . 25 mmHg . at rest. , . as measured at right heart catheterisation.. N. ormal . mean. pulmonary artery . pressure?! . Maureen A. Mealy, RN, BSN, Daniel Becker MD, Scott D. Newsome, DO,. John . N. Ratchford, MD, Michael Levy, MD, PhD, Carlos A. Pardo, MD. The Johns Hopkins Transverse Myelitis Center performed a retrospective analysis . Prof Paul A . Corris. Newcastle University. Newcastle Upon Tyne. Pulmonary Hypertension. Which of the following statements are true. A breathless patient with normal LV systolic function and whose RHC results show a mean PAP of 30 mmHg and a PCW of 23 mmHg has pulmonary arterial hypertension. Hypertension . doubles the risk of cardiovascular diseases, including coronary heart disease (CHD), congestive heart failure (CHF), ischemic and hemorrhagic stroke, renal failure, and peripheral arterial disease. Lancet Respir Med 2016Published Online € Pulmonary hypertension is becoming an increasingly Pulmonary arterial hypertension, especially the idiopathic form, although still a rare disease with an DR. NISHI. Assistant Professor. Department of Pathology. SKMCH, . Muzaffarpur. Pulmonary Diseases . of Vascular Origin. Pulmonary Embolism and Infarction. Pulmonary Hypertension. Diffuse Pulmonary . Hemorrhage. . Bettamer. Zikoecho@yahoo.com. Friday, March 08, 2019. 67 years Old male presented with acute dyspnea, . Pleuritic. Right side chest pain and hemoptysis , with history of recent pelvic fracture post RTA one week back.. Khaled Al Oweidat, MD. PE. Introduction . Partial or complete occlusion of a pulmonary arterial branch by blood clot(thrombus or multiple thrombi).. Deep vein thrombosis and PE are different presentations of the same underlying pathophysiological event, venous thromboembolism (VTE)..